Interview with Professor Dame Ijeoma Uchegbu

Ahead of Dame Ijeoma's talk on nanomedicine, we had the chance to ask her some questions

test image - need permission

Q: What part of your career would have most impressed your teenage self? 

A: The fact that I designed a medicine component from scratch that has now been tested in humans and has the potential to make a difference to healthcare.

 

Q: What has been the most surprising breakthrough in which you have been involved? 

A: The fact that a small chemical change to a protein in our body, changes the way that protein interacts with cells – allowing it to act as a specific drug transporter into cancer cells. This was a surprising finding.

 

Q: What branches of medicine do you think will be most impacted by your team’s work on nanomedicine?

 A: Our focus is now on ophthalmology and so we are hoping to be able to make an impact on eyecare.

 

Q: How hopeful are you that the work of your team will be able to impact global healthcare rather than the healthcare of the most wealthy? 

A: This is something that we are always concerned about and we would hope that our medicines would not be too expensive and thus have an impact on a variety of populations.

 

Q: Your profile shows that you are frequently involved in encouraging diversity in academic study and STEM in particular.  What advice would you have for bright young people who enjoy science but think that academic research might not be for “people like them”?

A: It is always difficult to give advice as an older woman.  I doubt that I would have taken advice from an older academic when I was comparatively young.  Here is the advice I wish I had been given and actually taken: There are no barriers that you cannot break and it would be foolish to assume that barriers do not exist, but we all have one goal – to go out and smash those barriers down by demonstrating our excellence in everything that we do.

 

Thank you to Dame Ijeoma for taking the time to answer our questions.

Professor Dame Ijeoma Uchegbu will be giving her talk – Small Particles, Big Impact: Revolutionising Drug Delivery – at the Renold Building, Manchester, on Thursday 20 March.

Image credit: Phil Mynott

Ijeoma Uchegbu

Professor Dame Ijeoma F Uchegbu FMedSci Hon FRSC

Professor Dame Ijeoma Uchegbu is a distinguished leader in pharmaceutical science and academia. She serves as President of Wolfson College, Cambridge, while holding the position of Professor of Pharmaceutical Nanoscience at UCL. As Chief Scientific Officer of Nanomerics Ltd., she leads the development of innovative medicines for sight-threatening illnesses. Her ground-breaking laboratory work has led to successful licensing agreements with Virpax Pharmaceuticals (NASDAQ:VRPX).

Her scientific excellence is widely recognized through fellowships with the Academy of Medical Sciences and honorary fellowship of the Royal Society of Chemistry. Technologies developed in her laboratory have earned prestigious awards from both the Royal Society of Chemistry and the Royal Pharmaceutical Society. Most recently, Nanomerics Ltd. received the King’s Award for Enterprise 2024 in the Innovation category – the UK’s most prestigious business award.

Professor Uchegbu’s influence extends beyond research through her service on several distinguished boards. She is a governor of the Wellcome Trust, one of the world’s largest biomedical research charities, and sits on the Academy of Medical Sciences Council. Her leadership roles have included Chair of the Academy of Pharmaceutical Sciences and Scientific Secretary of the Controlled Release Society.

As the immediate past UCL Provost’s Envoy for Race Equality, Professor Uchegbu has been a powerful advocate for change in academia. Her work led to the landmark decision to remove eugenicists’ names from UCL buildings in 2020. She has addressed the UK House of Commons on educational racial disparities and their impact on ethnic minority representation in scientific research.

Professor Uchegbu’s forthcoming popular science book, Chain Reaction: A Journey into the Chemistry that Shapes Us, will be published by Hodder and Stoughton in 2026. Her significant contributions to British society are recognized by her inclusion in Bloomsbury Publishing’s Who’s Who 2024. She was made Dame Commander of the British Empire (DBE) in the King’s New Years Honours 2025.

Sign up to our newsletter

Sign up to our e-newsletter to receive exclusive content and all the latest Lit & Phil news

* indicates required